AACR

14 kwietnia 2018

AACR Annual Meeting 2018, 14-18 April 2018, Chicago, IL, USA

Rok

2018

Cel

RVU120 (CDK8/CDK19), A2A/A2B, SHMT

Zasoby na tej stronie

Pobierz zasoby

  • plik pdf

    "Characterization of novel dual A2A/A2B adenosine receptor antagonists for cancer immunotherapy"

    Pobierz
  • plik pdf

    "CDK8 inhibitor SEL120-34A targets CD34 positive AML cells by regulation of transcriptional programs involved in the maintenance of leukemia stem cells"

    Pobierz
  • plik pdf

    "Discovery of novel SHMT small molecule inhibitors for cancer treatment"

    Pobierz